Purpose: To assess the uptake, accumulation, temporal stability, and spatial localization of isoflurane (ISO) in the C57BL/6 mouse, and to identify its potential interference with the detection of labeled cardiac progenitor cells using 19 
effects. 12 Isoflurane (CF 3 CH 2 ClOCHF 2 ) contains two groups (moieties) of 19 F atoms, which give rise to two peaks (with chemical shifts of -4 and -10.3 ppm with respect to CFCl 3 ) in the NMR spectrum. These peaks may interfere with the detection of fluorinated agents in vivo (chemical shift range of -126.6-9.1 ppm with respect to CFCl 3 and -50-86 ppm with respect to trifluoroacetic acid [TFA]) due to potential spectral overlaps. Furthermore, despite the existence of numerous prior 19 F MRI studies on the uptake and clearance characteristics of ISO in the brain in vivo, [14] [15] [16] [17] the localization of ISO in cardiac thoracic and peripheral skeletal tissues, its bio-distribution, accumulation, kinetics, and possible interference with 19 F labels has not been investigated in detail. Additionally, only a few reported cardiovascular applications of fluorinated agents exist, 18, 19 and investigations into the possible implications of the use of ISO have been speculative. 20 Specifically, Fl€ ogel et al. 18 and van Heeswijk et al. 19 have, respectively, demonstrated successful cardiac and vascular 19 F MR imaging in the mouse thorax following injection of PFC emulsions into the venous circulation. While Fl€ ogel et al. 18 do not discuss the impact of the presence of ISO on the imaging of 19 F emulsions, van Heeswijk et al. 19 have shown minimal ISO accumulation of the anesthetic in the thoracic vascular space, and have quantified the relative spectral shifts from the injected agents. More recently, Fox et al. 20 have argued that the use of ISO should have a minimal impact on the 19 F MR images of PFC agents, and have suggested the use of selective radiofrequency (RF) excitation to ameliorate any potential issues; however, their discussion is speculative and lacks direct experimental evidence. The scope of this study is generalized on the accumulation of ISO (in striated skeletal and cardiac muscles). It extends beyond the two prominent prior 19 F MRS/MRI publications that focused on cardiovascular applications, 18, 19 whereby direct injections of labeled emulsions were achieved by means of the intravenous route. Their reported approach 18, 19 exhibits bio-distribution, delivery, temporal dynamics, and label dilution differences, compared with current state-of-the-art schemes using either direct injections (adopted strategy in this study), or scaffold-based, 19 F labeled, cardiac progenitor stem cell administrations.
Therefore, the objectives of this study are to: (a) determine the spatial localization of ISO in the thoracic and peripheral skeletal muscle areas of the C57BL/6 mouse, and quantitatively assess its uptake, accumulation, and temporal stability within a period of 90 min postinduction, including its potential accumulation in the ventricular blood pool, and myocardium, (b) define the spectral characteristics of the ISO moieties in vivo, (c) identify the spectral characteristics of extensively used 19 F labels, and assess their potential spectral overlaps and interference with respect to ISO, including the extensively used perfluoro-crown-ether (PFCE) label, using 19 F MRS/MRI.
Materials and Methods

Animal Ethics
All procedures were approved by the local ethical review committee (U. Oxford), and conformed to the Animal (Scientific Procedures) Act 1986 (UK) incorporating European Directive 2010/63/EU.
MRI
All experiments were conducted on a 9.4Tesla (T) Agilent scanner equipped with a DirectDrive console and a 1 mT/m actively shielded gradient set (internal diameter 5 60 mm) (Agilent Technologies, Santa Clara, CA).
RADIOFREQUENCY COILS. An eight-rung, low-pass quadrature birdcage coil (internal diameter 5 34 mm), was constructed inhouse, tuned and matched at 375. F MR images were acquired in mice (thoracic area) using a segmented k-space, prospectively electrocardiograph-(ECG-) and respiratory-gated (double-gated) spoiled gradient echo (SPGR) sequence. A three-dimensional (3D) SPGR sequence (ungated) was used for the post-mortem imaging (hind-limb skeletal muscle areas).
For MRS, the temporal evolution of ISO accumulation was monitored using nonlocalized, fully relaxed, pulse-acquire spectra. 
Cells
NANOPARTICLE FORMULATION. Particles were synthesized in accordance to previously published methodologies. 22, 23 In brief, nanoparticles ($200 nm in diameter) with entrapped PFCEs were synthesized using poly(lactic-co-glycolic acid) (PLGA). All particles were washed extensively with distillated water and lyophilized for 3-4 days. Prior
19
F MRS characterization of PFCE NPs has confirmed a single spectral peak at -16.00 ppm (with respect to TFA).
CELL ISOLATION. Cardiac progenitor cells comprising either collagenase-trypsin (CT) or cardiosphere-derived cells (CDC)] were isolated from adult, C57BL/6, GFP positive, mouse atria, using standard protocols. 24, 25 LABELING. Cells were subsequently incubated with PFCEcontaining NPs (loading concentration of 10 mg/ml/million cells) for approximately 24 h before trypsinization, isolation, and washing. Cell pellets were suspended and maintained in IMDM media and were used for MRI, flow cytometry, or confocal microscopy (after fixation in 2% paraformaldehyde solution). Successful labeling was confirmed with a CyAn ADP flow cytometer (Beckman Coulter, Brea, CA) using control and labeled cell samples.
In Vivo and Post-mortem Murine MRI/MRS
PHYSIOLOGY. To ascertain the temporal effects of anesthesia, ISO was administered in three C57BL/6 mice (male [mean 6 SD], 24.6 6 3.6 g, weight range 5 25.0-27.2 g). The mice were induced using 4% ISO, and were maintained for up to 95 min with 1.5-2.0% ISO, mixed in 100% oxygen.
All animals were placed in a specially constructed cradle (www.civm.duhs.duke.edu), and were allowed to breathe freely throughout the study. A homeostatically controlled hot-air system was used to maintain mouse body temperature at approximately 37 8C. ECG and breathing rates were monitored using a gating system. 26 Heart rates were maintained at 382-565 beats/min.
One additional C57BL/6 mouse (male, weight 5 32.4 g) was euthanized with an overdose of ISO (5%) and was subsequently injected in the femoral area of the right hindlimb with labeled CDC cells, transferred to a butterfly coil, and then re-imaged post-mortem. Corresponding spectrum of a 75 mM trifluoroacetic acid (TFA) phantom (50 mL). C: Spectrum of a 25 mM TFA phantom in the presence of collagenase-trypsin (CT) progenitor cells labeled using PFCEcontaining NPs (arrow). The NP resonance (-16.25 ppm) is distinct from the TFA resonance (0 ppm). D: Typical spectrum of ISO signals (corresponding to the -CF 3 and -OCHF 2 moieties) in a mouse in vivo. The spectrum was collected and averaged over a period of 5 min. All spectra were acquired using a birdcage coil.
Spectra were processed in CSX (P. Barker, Johns Hopkins, USA) or using custom-written IDL tools (Harris Geospatial, USA). For temporal ISO comparisons, peak integrals were estimated from gated, magnitude spectra.
STATISTICAL ANALYSES. All results are reported as mean 6 SD. The temporal constancy of the spectral areas for both ISO resonances is quantified using the coefficient of variability (CV 5 100 3 SD/ Mean). Repeated-measures, nonparametric, two-tailed Student t-tests, were also used (XLSTAT, Addinsoft, New York) to determine whether the ISO dose reduction (2.0% to 1.7%) caused significantly different changes in the areas of the spectral peaks (a 5 5%).
Results
Typical nonlocalized pulse-acquire (Fig. 1D ) that, respectively, correspond to the -CF 3 , and -OCHF 2 moieties. 14, 17, 19 Noted also is a downfield spectral shift of the ISO resonances in vivo by approximately -4 ppm, and an increase in the spectral linewidth of the -CF 3 peak to 500 Hz. The spectral separation of the two ISO resonances in vivo is $6.3 ppm (Table 1) . Taken together, Figure 1C , D indicates that PFCE-labeled CT cells exhibit spectral separations of -11.25 and -4.95 ppm from the -CF 3 and -OCHF 2 resonances of ISO, respectively. Figure 2 shows the in vivo temporal evolution of the nonlocalized, pulse-acquire ISO signals (corresponding to the -CF 3 and -OCHF 2 moieties) at 5 min intervals from a typical mouse. To assess any changes in the in vivo 19 F spectrum of ISO with time or dose, the areas of both ISO peaks were quantified using CSX, and the ISO dosage was decreased from 2.0% to 1.7% at t 5 80 min postinduction (see Fig. 3 ).
The CV of the ISO peaks for each of the studied mice and for the entire cohort (during the time period of 50-90 min postinduction) were: (a) 6.4, 3.9, 3.2, and 3.9% (-CF 3 ), and (b) 11.2, 6, 8.5, and 6.4% (-OCHF 2 ). 
Discussion
This study demonstrates ISO accumulation in thoracic areas of the mouse. The results also demonstrate that the presence of ISO does not constitute a problem for the detection and quantification of PFCE in cardiac labeled cells. 20 Herein, the two expected peaks of the NMR spectrum of ISO were observed both in vitro and in vivo. ISO exhibited chemical shifts of -4.0 (CF 3 ) and -10.3 ppm (-OCHF 2 ) in C57BL/6 mice in vivo with respect to the TFA resonance at 0 ppm, confirming previous reports in rabbits, and C57BL/6 and BALB/c mice. 14, 19, 27 The downfield shift of ISO in vivo has been attributed to the chemical structure and the microenvironment in which ISO resides. 14 It is also of interest to note that the chemical shift of the -CF 3 resonance is either co-resonant with (in vitro) or close to (in vivo) the TFA resonance. Consequently, TFA reference phantoms cannot be used in ISO/NP label studies because the signal overlap can lead to inaccuracies in calibration and quantification. Instead, NaF (-44.95 ppm) or potassium fluoride (-46.75 ppm) phantoms may be preferred because their chemical shifts do not overlap with those of the ISO moieties. Substantial accumulation of ISO was observed in the live mouse as documented by 19 F MRS. Prior work in vivo reports that the uptake and equilibration of ISO and sevoflurane in the brain is extremely fast (of the order of minutes), 15, 17, 28 compared with the ISO release which appears to be extremely slow (of the order of 72-98 h). 14, 15, 28 The results presented in this study show constancy and temporal stability of the evoked ISO spectra from anesthetized mice within time periods spanning 35-90 min postinduction. These findings are reinforced by the lack of statistically significant differences in the ISO signal amplitude following dose decreases. Additionally, the post-mortem study confirmed persistence of ISO in thoracic and skeletal muscle areas for at least 7 h post-euthanasia, consistent with prior literature. [14] [15] [16] Thus, longitudinal studies with repeated imaging sessions may be affected by ISO accumulation. This issue has been overcome in prior work with the use of alternative anesthetics. 20, 29 Noted also were significant increases in the linewidths of both ISO peaks attributed to either temporal, or physiologically dependent factors. From the physiological standpoint, the acquired spectra represent nonlocalized, spatiotemporal averaged signals that may be prone to: (a) beat-to-beat variations, (b) overall effects from ISO distribution (as a result of intraspecies variations in weight, body muscle/fat composition), and (c) heterogeneity of signal contribution arising from multiple organs and multiple T 2 entities. From the technical standpoint, primary effects may be attributed to: (a) shimming, (b) B 0 /B 1 effects (leading to flip-angle dependencies and off-resonance effects), and (c) the inability to resolve multiplet patterns from the respective spectral splitting of the two ISO moieties, ultimately leading to two distinct, broadened, peaks. Certainly, the in vivo ISO peak intensities are substantially larger than that of the PFCE spectral intensity arising from the labeled cells.
From the biophysical standpoint, it is expected that the observed linewidth changes are attributed primarily to shortened T 2 or T Ã 2 values, or to poor B 0 homogeneity over 14 in rabbit brains) indicate the existence of either suboptimal shimming, or ultrashort T 2 moieties and/or a heterogeneous, multifocal pattern of ISO accumulation in lipid, blood, and other tissue areas. Our results are in agreement with Xu et al. 15 who have presented evidence for ultrashort T 2 anesthetic moieties (<3 ms) in the brain in rats as a result of intracranial skeletal muscle/fat accumulations (14) , despite the lack of significant lipid accumulations/contributions as reported in a recent study by van Heeswijk et al. 19 Given the chemical shift difference between the ISO resonance of the -OCHF 2 moiety with respect to the PFCE resonance of cardiac progenitor-labeled cells, and in conjunction with the selective acquisition bandwidths used in 19 F MRI, we have shown negligible ISO effects on the imaging of 19 F signals arising from PFCE labels in vitro, and in post-mortem skeletal muscle imaging in the mouse. Combined selective excitation/suppression schemes can be used to excite the PFC label and minimize baseline drifts due to possible contaminating effects from -OCHF 2 . This is particularly important given the multifold 19 F signal difference of labels in cells compared with the ISO moieties, particularly considering the expected submillimolar label concentrations in cells. [29] [30] [31] The downside of selective excitation and prepulse suppression is the prolongation of TE. Nevertheless, in the case of the PFCE NPs, such effects are anticipated to be minimal, given their long T 2 responses in the range of 50-600 ms. 7 However, with the use of other commonly used 19 F labels, such as perfluoropolyether (PFPE), perfluorodecalin (PFD), trans-bis-perfluorobutyl ethylene (F-44E), or perfluorooctyl bromide (PFOB), 23, 32 there is a significant potential for overlap of these labels and the ISO peaks, 1 H (C) and (D) 19 F images of the ISO peaks were acquired using the butterfly coil. The spatial boundaries of the right hindlimb obtained from the 1 Despite the technical complexity of this work, there are several limitations in the study design. For example, despite the consistency of the effects of ISO observed in the male mice of this study, and in preliminary studies in female mice (results not shown), the sample sizes were small. Therefore, possible sex differences in the ISO effects need to be accounted for in large-sample studies. Furthermore, the reported effects of temporal accumulation of ISO and its biodistribution, as well as the spectral response of the PFCE NPs must be assessed in models of pathology, including myocardial infarction and skeletal myopathies. Of more importance may be also the generalizability of the study and its extension to larger animal models (e.g., rats or pigs) in larger bore, lowerfield magnets. However, migration of the work may impose further challenges in terms of the separability of the ISO and PFCE NP spectra. Thus, a more appropriate study design may also include the characterization of the T 1 relaxation values for both anesthetic moieties, and the selective inversion of the undesired spectral peaks in conjunction with the selective excitation of the peaks corresponding to the labels.
In conclusion, accumulation of ISO was observed in the mouse with signals that are temporally stable over 90 min post-induction, as documented by 19 F MRS. The temporal persistence of ISO spans multiple hours. Given the spectral separation of the ISO peaks from the PFCE resonance, and the selective acquisition bandwidths often used in 19 F MRI, the anticipated signal overlap/contamination effects of ISO on PFCE labels are minimal, but may be more prominent for PFPE or PFOB labels. Correspondingly, ISO still remains the primary choice for 1 H and multinuclear imaging studies.
